መነሻ › ሙያዎች › Medical and Clinical Laboratory Technologists › Boston, MA
Medical and Clinical Laboratory Technologists በBoston፣ MA፡ የH-1B ደመወዞች
39 የሥራ ሁኔታ ማመልከቻዎች ለዚህ ሙያ ከሥራ ቦታ ጋር በBoston፣ MA። መካከለኛ የቀረበ መሠረታዊ ደመወዝ $77,626፤ መካከለኛ ግማሽ $65,000–$84,758።
ማመልከቻዎች (LCAs)39
መካከለኛ የሚቀርብ ደመወዝ$77,626
የደመወዞች መካከለኛ ግማሽ$65,000–$84,758
ከ10ኛ እስከ 90ኛ ፐርሰንታይል$56,576–$97,906
በደመወዝ ደረጃ
| የደመወዝ ደረጃ | መካከለኛ ደመወዝ |
|---|---|
| ደረጃ I (መግቢያ) | $60,788 |
| ደረጃ II (ብቁ) | $78,616 |
| ደረጃ III (ልምድ ያለው) | $84,917 |
| ደረጃ IV (ሙሉ ብቃት ያለው) | $77,278 |
የሥራ ሚኒስቴር ለእያንዳንዱ ሙያ እና አካባቢ ከደረጃ I (መግቢያ) እስከ ደረጃ IV (ሙሉ በሙሉ ብቁ) ድረስ አራት የሚገባ ደመወዝ ደረጃዎችን ይወስናል። አሠሳሪው ከሥራው መስፈርቶች ጋር የሚስማማውን ደረጃ ይመርጣል።
አሠሪዎች
| አሠሪ | LCAs | መካከለኛ ደመወዝ |
|---|---|---|
| Children's Hospital Corporation | 8 | $93,008 |
| Beth Israel Deaconess Medical Center, Inc. | 6 | $80,475 |
| Brigham and Women's Hospital | 6 | $81,535 |
| Management Health Systems, LLC | 5 | $56,576 |
| Boston Medical Center Corporation | 4 | $73,592 |
| General Hospital Corporation | 2 | $87,360 |
| Allotex | 2 | $77,626 |
| Tufts Medical Center, Inc. | 1 | $73,000 |
| Massachusetts Eye and Ear Infirmary | 1 | $65,000 |
| Invitrx Therapeutics, Inc. | 1 | $75,000 |
| Interon Laboratories, Inc. | 1 | $82,839 |
| Laboratory Corporation of America Holdings | 1 | $70,574 |
| Dana-Farber Cancer Institute | 1 | $65,000 |
የሥራ መደቦች
- Medical Technologist II9
- Clinical Laboratory Scientist5
- Medical Technologist4
- Cytogenetics Technologist3
- Medical Lab Scientist II2
- Tissue Processing Specialist2
- Ophthalmic Technician III1
- Medical Lab Scientist I1
- Lead Laboratory Technician1
- Cytotechnologist1
- Molecular Diagnostic Technologist II1
- Medical and Clinical Technologist1
- Sr. Medical Technologist1
- Sr. Medical Laboratory Scientist 11
- Clinical Laboratory Supervisor - Molecular Diagnostics1
ደመወዞች በእያንዳንዱ ማመልከቻ ላይ በተገለጸው ደመወዝ ዝቅተኛ ጫፍ ሲሆኑ ወደ ዓመታዊ መጠን ተቀይረዋል፤ ስታቲስቲክሶች የተረጋገጡ ሙሉ ጊዜ ማመልከቻዎችን ብቻ ይጠቀማሉ። LCA የቪዛ ማረጋገጫ አይደለም፤ አንድ LCA ለብዙ ቦታዎች ሊሸፍን ይችላል። ምንጭ፡ የአሜሪካ የሥራ ሚኒስቴር፣ OFLC LCA መረጃ ማሳያ መረጃ፣ የፋይናንስ ዓመታት 2023–2026 (የቅርብ ጊዜ ውሳኔ 30 ጁን 2026)።